1. Repository of OAI
Ελληνικά   English  

Browsing by Author Kostapanos, M. S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 14 to 33 of 34 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Editorial: reducing cardiovascular risk: is low-density lipoprotein-cholesterol (LDL-C) lowering enough?Kostapanos, M. S.; Katsiki, N.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Effect of Ezetimibe on Markers of Oxidative Stress in Patients with HypercholesterolemiaKostapanos, M. S.; Spyrou, A. T.; Tellis, C. C.; Gazi, I. F.; Tselepis, A. D.; Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015-
Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemiaKostapanos, M. S.; Derdemezis, C. S.; Filippatos, T. D.; Milionis, H. J.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
EFFECT OF STANDARD COMBINATION OF VALSARTAN WITH EITHER AMLODIPINE OR HYDROCHLOROTHIAZIDE ON LDL SUBFRACTION PROFILE IN PATIENTS WITH HYPERTENSIONChristogiannis, L. G.; Kostapanos, M. S.; Milionis, H. J.; Mitrogianni, Z.; Moutzouri, E.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Effects of Orlistat and Fenofibrate, Alone or in Combination, on Plasma Apolipoprotein C-Ii and C-Iii Levels in Metabolic Syndrome PatientsFilippatos, T. D.; Kostapanos, M. S.; Kostara, C.; Nakou, E. S.; Georgoula, M.; Derdemezis, C. S.; Kiortsis, D. N.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective studyRizos, C. V.; Milionis, H. J.; Kostapanos, M. S.; Florentin, M.; Kostara, C. E.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015-
Efficacy and safety of ezetimibe plus orlistat or rimonabant in statin-intolerant nondiabetic overweight/obese patients with dyslipidemiaFlorentin, M.; Kostapanos, M. S.; Nakou, E. S.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015-
Ezetimibe Treatment Lowers Indicators of Oxidative Stress in Hypercholesterolemic Subjects with High Oxidative StressKostapanos, M. S.; Spyrou, A. T.; Tellis, C. C.; Gazi, I. F.; Tselepis, A. D.; Elisaf, M.; Liberopoulos, E. N.24-Nov-2015-
High-Density Lipoprotein Subclasses in Patients with or without the Metabolic SyndromeLagos, K. G.; Gazi, I. F.; Kostapanos, M. S.; Filippatos, T.; Kazakou, P. S.; Rizos, C. V.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in womenGazi, I. F.; Milionis, H. J.; Filippatos, T. D.; Tsimihodimos, V.; Kostapanos, M. S.; Doumas, M.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Hypertriglyceridaemic waist phenotype definitions and prevalent metabolic triad in womenGazi, I. F.; Milionis, H. J.; Filippatos, T. D.; Kostapanos, M. S.; Saougos, V. G.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndromeMilionis, H. J.; Kostapanos, M. S.; Vakalis, K.; Theodorou, I.; Bouba, I.; Kalaitzidis, R.; Georgiou, I.; Elisaf, M. S.; Siamopoulos, K. C.24-Nov-2015-
The impact of the metabolic syndrome on health-related quality of life: A cross-sectional study in GreeceTziallas, D.; Kastanioti, C.; Kostapanos, M. S.; Skapinakis, P.; Elisaf, M. S.; Mavreas, V.24-Nov-2015-
JUPITER and satellites: Clinical implications of the JUPITER study and its secondary analysesKostapanos, M. S.; Elisaf, M. S.24-Nov-2015-
Modelling eating practices in non-fatal acute coronary syndrome or stroke development: A case/case-control studyKastorini, C. M.; Milionis, H. J.; Georgousopoulou, E.; Kostapanos, M. S.; Yannakoulia, M.; Nikolaou, V.; Vemmos, K. N.; Goudevenos, J. A.; Panagiotakos, D. B.24-Nov-2015-
An overview of the extra-lipid effects of rosuvastatinKostapanos, M. S.; Milionis, H. J.; Elisaf, M. S.24-Nov-2015-
Phenotype determinants of the thiglycerides lowering effect of rosuvastatinKostapanos, M. S.; Milionis, H. J.; Filippatos, T. D.; Saougos, V. G.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Rosuvastatin increases alpha-1 microglobulin urinary excretion in patients with primary dyslipidemiaKostapanos, M. S.; Milionis, H. J.; Gazi, I.; Kostara, C.; Bairaktari, E. T.; Elisaf, M. S.24-Nov-2015-
Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucoseKostapanos, M. S.; Milionis, H. J.; Agouridis, A. D.; Rizos, C. V.; Elisaf, M. S.24-Nov-2015-
Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemiaKostapanos, M. S.; Milionis, H. J.; Elisaf, M. S.24-Nov-2015-
Showing results 14 to 33 of 34 < previous   next >